| Elondra Varice, | |
|
3285 122nd Ave, Allegan, MI 49010-9511 | |
| (269) 615-5117 | |
| Not Available |
| Full Name | Elondra Varice |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 3285 122nd Ave, Allegan, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588148191 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 6801115581 (Michigan) | Primary |
| Entity Name | Allegan County Community Mental Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215989231 PECOS PAC ID: 1153317607 Enrollment ID: O20040421001240 |
News Archive
People wondering about excessive weight gain might look to their relationships with family and friends for one clue, suggests new research reported July 26, 2007, in The New England Journal of Medicine.
Malnutrition problems can be traced to poor-quality diets lacking in diversity, a recent phenomenon in evolutionary history, according to a new paper from the Brown School at Washington University in St. Louis.
The Guardian examines a new Millennium Villages Project (MVP) - "the integrated approach to rural development spearheaded by Jeffrey Sachs of Columbia University's Earth Institute" - that was launched last week in northern Uganda "by Ghana's new president John Dramani Mahama and U.K. international development secretary Andrew Mitchell."
A recent presentation at an international cancer research conference in Greece reviewed the body of data on ProstaCaid, a dietary supplement compound for prostate health. A number of published studies demonstrate the formula's effects in supporting prostate health against specific prostate cancer cell lines and prostate urinary symptoms.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of a Phase 3 registration trial of custirsen sodium (OGX-011/TV-1011), its lead product candidate being developed for the treatment of castrate-resistant prostate cancer (CRPC). This trial, referred to as the Prostate Cancer SATURN Trial, is the first of three Phase 3 trials to be initiated under a global collaboration and license agreement between OncoGenex and Teva Pharmaceutical Industries to develop and commercialize OGX-011/ TV-1011.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elondra Varice, 1333 Oshtemo Ridge Trl, Kalamazoo, MI 49009-3705 Ph: (269) 352-3679 | Elondra Varice, 3285 122nd Ave, Allegan, MI 49010-9511 Ph: (269) 615-5117 |
News Archive
People wondering about excessive weight gain might look to their relationships with family and friends for one clue, suggests new research reported July 26, 2007, in The New England Journal of Medicine.
Malnutrition problems can be traced to poor-quality diets lacking in diversity, a recent phenomenon in evolutionary history, according to a new paper from the Brown School at Washington University in St. Louis.
The Guardian examines a new Millennium Villages Project (MVP) - "the integrated approach to rural development spearheaded by Jeffrey Sachs of Columbia University's Earth Institute" - that was launched last week in northern Uganda "by Ghana's new president John Dramani Mahama and U.K. international development secretary Andrew Mitchell."
A recent presentation at an international cancer research conference in Greece reviewed the body of data on ProstaCaid, a dietary supplement compound for prostate health. A number of published studies demonstrate the formula's effects in supporting prostate health against specific prostate cancer cell lines and prostate urinary symptoms.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of a Phase 3 registration trial of custirsen sodium (OGX-011/TV-1011), its lead product candidate being developed for the treatment of castrate-resistant prostate cancer (CRPC). This trial, referred to as the Prostate Cancer SATURN Trial, is the first of three Phase 3 trials to be initiated under a global collaboration and license agreement between OncoGenex and Teva Pharmaceutical Industries to develop and commercialize OGX-011/ TV-1011.
› Verified 3 days ago
Mr. David M Green, MA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 327 Hubbard St, Allegan, MI 49010 Phone: 269-673-1929 Fax: 269-686-0373 | |
Ms. Janice Marie Zwaanstra, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 217 Hubbard St, Allegan, MI 49010 Phone: 269-673-1896 | |
Mrs. Kimberly Thomas, LLMSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 3285 122nd Ave, Allegan, MI 49010 Phone: 269-355-2068 | |
Savannah Storey, LLMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3283 122nd Ave, Allegan, MI 49010 Phone: 269-512-4395 | |
Patrick Hoekstra, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 221 Trowbridge St, Allegan, MI 49010 Phone: 616-648-4411 | |
Kathryne Boerman, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 213 Hubbard St, Allegan, MI 49010 Phone: 269-673-1896 | |
Mrs. Jennifer Renee Hudson, LMSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 551 Linn St Ste 230, Allegan, MI 49010 Phone: 269-686-4110 |